IL125534A - Unit dose of budesonide and use thereof for nasal administration - Google Patents
Unit dose of budesonide and use thereof for nasal administrationInfo
- Publication number
- IL125534A IL125534A IL12553497A IL12553497A IL125534A IL 125534 A IL125534 A IL 125534A IL 12553497 A IL12553497 A IL 12553497A IL 12553497 A IL12553497 A IL 12553497A IL 125534 A IL125534 A IL 125534A
- Authority
- IL
- Israel
- Prior art keywords
- budesonide
- unit dose
- nasal administration
- mug
- nose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9604486A SE9604486D0 (sv) | 1996-12-05 | 1996-12-05 | Novel formulation |
US08/846,960 US6291445B1 (en) | 1996-12-05 | 1997-04-29 | Low dose budesonide formulations and uses thereof |
PCT/SE1997/001998 WO1998024450A1 (en) | 1996-12-05 | 1997-11-28 | Novel formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
IL125534A0 IL125534A0 (en) | 1999-04-11 |
IL125534A true IL125534A (en) | 2003-06-24 |
Family
ID=26662810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12553497A IL125534A (en) | 1996-12-05 | 1997-11-28 | Unit dose of budesonide and use thereof for nasal administration |
Country Status (23)
Country | Link |
---|---|
US (2) | US6686346B2 (xx) |
EP (1) | EP0907365B1 (xx) |
JP (1) | JP2000508675A (xx) |
CN (1) | CN1168450C (xx) |
AT (2) | ATE369118T1 (xx) |
AU (1) | AU726515B2 (xx) |
BE (1) | BE1011394A5 (xx) |
CZ (1) | CZ295792B6 (xx) |
DE (2) | DE69721766T2 (xx) |
DK (1) | DK0907365T3 (xx) |
ES (1) | ES2133130B1 (xx) |
FR (1) | FR2756739B1 (xx) |
GR (1) | GR1003011B (xx) |
HK (1) | HK1020522A1 (xx) |
HU (1) | HUP0000575A3 (xx) |
IE (1) | IE970854A1 (xx) |
IL (1) | IL125534A (xx) |
NL (1) | NL1007706C2 (xx) |
NO (1) | NO983555L (xx) |
NZ (1) | NZ330925A (xx) |
PT (1) | PT907365E (xx) |
TR (1) | TR199801501T1 (xx) |
WO (1) | WO1998024450A1 (xx) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2756739B1 (fr) * | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
MY133181A (en) * | 1998-09-10 | 2007-10-31 | Schering Corp | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
AR026073A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
AU2002337692B2 (en) | 2001-09-26 | 2007-09-13 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
US9808471B2 (en) * | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
US7811606B2 (en) | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20050026887A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a steroid |
WO2005027853A2 (en) * | 2003-09-19 | 2005-03-31 | University Of Louisville Research Foundation Inc | Method for treating snoring and sleep apnea with leukotriene antagonists |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US8679545B2 (en) * | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US20070110788A1 (en) * | 2005-11-14 | 2007-05-17 | Hissong James B | Injectable formulation capable of forming a drug-releasing device |
US7976873B2 (en) * | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
US20070264296A1 (en) * | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
US7993675B2 (en) * | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
US7959943B2 (en) * | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
ES2298049B1 (es) * | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano. |
US8088095B2 (en) | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
ES2493641T3 (es) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Administración nasal de soluciones acuosas de corticosteroides |
CA2608561A1 (en) * | 2007-10-29 | 2009-04-29 | Carl Paluszkiewicz | Motorcycle wind deflector accessory support |
US20090143343A1 (en) * | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
JP2011503073A (ja) | 2007-11-13 | 2011-01-27 | メリテイジ ファーマ,インク. | コルチコステロイド組成物 |
US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
EP2100598A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
US20090264392A1 (en) * | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
RU2513142C2 (ru) | 2008-06-12 | 2014-04-20 | Медтроник Ксомед Инк. | Способ лечения хронических ран |
EP2346324A4 (en) | 2008-10-06 | 2012-10-10 | Microbial Defense Systems Llc | ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING |
WO2010144865A2 (en) * | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
US10653133B2 (en) | 2011-05-10 | 2020-05-19 | Next Science IP Holdings Pty Ltd | Antimicrobial solid and methods of making and using same |
CN112516087B (zh) * | 2020-12-24 | 2023-03-24 | 四川普锐特药业有限公司 | 布地奈德鼻喷剂及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE378109B (xx) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
US3992534A (en) * | 1972-05-19 | 1976-11-16 | Ab Bofors | Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods |
PL164294B1 (pl) * | 1990-12-20 | 1994-07-29 | Inst Farmaceutyczny | Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL |
HU0004452D0 (xx) * | 1991-12-18 | 2001-01-29 | Astra Ab | |
GB2269992A (en) * | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
US5509404A (en) | 1994-07-11 | 1996-04-23 | Aradigm Corporation | Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values |
AU6392496A (en) | 1995-06-29 | 1997-01-30 | Mcneil-Ppc, Inc. | The combination of topical nasal antihistamines and topical nasal steroids |
AU6290396A (en) * | 1995-06-29 | 1997-01-30 | Mcneil-Ppc, Inc. | The combination of topical nasal mast cell stabilizers and topical nasal steroids |
EP0780127A1 (en) * | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
EP0954318A1 (en) * | 1996-06-04 | 1999-11-10 | The Procter & Gamble Company | A nasal spray containing an intranasal steroid and an antihistamine |
FR2756739B1 (fr) * | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
SE9604486D0 (sv) * | 1996-12-05 | 1996-12-05 | Astra Ab | Novel formulation |
-
1997
- 1997-11-21 FR FR9714662A patent/FR2756739B1/fr not_active Expired - Fee Related
- 1997-11-27 ES ES009702483A patent/ES2133130B1/es not_active Expired - Fee Related
- 1997-11-28 AT AT02028325T patent/ATE369118T1/de not_active IP Right Cessation
- 1997-11-28 NZ NZ330925A patent/NZ330925A/xx unknown
- 1997-11-28 AT AT97948065T patent/ATE239482T1/de not_active IP Right Cessation
- 1997-11-28 AU AU54211/98A patent/AU726515B2/en not_active Ceased
- 1997-11-28 WO PCT/SE1997/001998 patent/WO1998024450A1/en not_active Application Discontinuation
- 1997-11-28 PT PT97948065T patent/PT907365E/pt unknown
- 1997-11-28 DE DE69721766T patent/DE69721766T2/de not_active Revoked
- 1997-11-28 DE DE69738000T patent/DE69738000T2/de not_active Revoked
- 1997-11-28 TR TR1998/01501T patent/TR199801501T1/xx unknown
- 1997-11-28 CZ CZ19982437A patent/CZ295792B6/cs not_active IP Right Cessation
- 1997-11-28 IL IL12553497A patent/IL125534A/xx not_active IP Right Cessation
- 1997-11-28 EP EP97948065A patent/EP0907365B1/en not_active Revoked
- 1997-11-28 DK DK97948065T patent/DK0907365T3/da active
- 1997-11-28 JP JP10525511A patent/JP2000508675A/ja not_active Ceased
- 1997-11-28 CN CNB971920796A patent/CN1168450C/zh not_active Expired - Fee Related
- 1997-11-28 HU HU0000575A patent/HUP0000575A3/hu unknown
- 1997-12-02 GR GR970100477A patent/GR1003011B/el not_active IP Right Cessation
- 1997-12-02 BE BE9700979A patent/BE1011394A5/fr not_active IP Right Cessation
- 1997-12-03 IE IE970854A patent/IE970854A1/en not_active IP Right Cessation
- 1997-12-05 NL NL1007706A patent/NL1007706C2/nl not_active IP Right Cessation
-
1998
- 1998-08-03 NO NO983555A patent/NO983555L/no unknown
-
1999
- 1999-10-13 HK HK99104513A patent/HK1020522A1/xx not_active IP Right Cessation
-
2001
- 2001-08-20 US US09/933,974 patent/US6686346B2/en not_active Expired - Fee Related
-
2003
- 2003-11-17 US US10/716,357 patent/US6986904B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL125534A0 (en) | A unit dose of budesonide and use thereof for nasal administration | |
SE9604486D0 (sv) | Novel formulation | |
GEP20043260B (en) | Aerosolized Active Agent Delivery and Device for Realization Thereof | |
MX9605650A (es) | Formulaciones de propionato de fluticasona. | |
GEP20002266B (en) | Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances | |
WO1994027589A3 (en) | Antidepressant dosage form | |
OA09868A (en) | Non-chorofluorocarbon aerosol formulation. | |
CA2212613A1 (en) | Nasal appliance | |
GR3032207T3 (en) | 2-Bromomelatonin in the therapy of sleep disorders | |
GB2365772A (en) | Factor | |
GR3021424T3 (en) | Use of 3-guanidinopropionic acid in the manufacture of a medicament for the treatment and prevention of excess adiposity | |
GB9918559D0 (en) | Novel pharmaceutical formulation | |
GB2305606B (en) | Drug delivery composition for the nasal administration of ICAM-1 | |
IL115589A0 (en) | Use of cck-b antagonists in pharmaceutical compositions | |
KR100213963B1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
IL120558A0 (en) | New hormonal medicaments and their use for the correction of oestrogenic deficiencies | |
HUT60438A (en) | Application of inhaled non-steroid inflammation reducers for potentiation of antireactive, antiasthmatic effect of inhaled henle's loop-diuretics | |
NZ303993A (en) | Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders | |
MY111755A (en) | Use of 4'-iodo-4'- deoxydoxorubicin for the treatment of amyloidosis. | |
EP1101493A3 (en) | New combination of formoterol and budesonide | |
GR3034062T3 (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
GB9401745D0 (en) | Improvements in and relating to the administration of medicaments or therapeutic substances | |
AU8195091A (en) | Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease | |
ZA968315B (en) | Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof | |
TW360538B (en) | Pharmaceutical composition containing 4'-iodo-4'-deoxydoxorubicin for treatment of amyloidosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
EXTP | Application for extension order is pending | ||
EXTN | Extension order renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees | ||
MM9K | Patent not in force due to non-payment of renewal fees |